• Emylee Thai
    Founder, Chief Happiness Officer

     

     

    Ms. Emylee Thai is the Founder of Artemis DNA. Having lost both her parents to cancer, it felt imperative for her to analyze her own cancer risk profile, sparking her interest in genetic testing. Through Artemis DNA, she is empowering the population to make more informed decisions about their health by making diagnostic testing more accessible. Artemis DNA provides an in-depth oncology portfolio which includes genetic risk profile assessment, early detection, tumor detection and management for recurrence of cancer. Emylee holds more than ten years of experience in the life science and biotechnology industries. She has liaised with renowned, top-tier healthcare organizations which utilize strategy, consulting, and technology to link top-notch medical care professionals with individuals worldwide during her professional career. Emylee is driven by a passion for delivering innovative, affordable, meaningful, and relevant healthcare and medical care solutions available across the nation.

    Ms. Thai is very active in the life science and biotechnology communities and believes in giving back. She recently started the Artemis DNA Foundation to facilitate free cancer screening and health education services. In addition to other accolades, she was recently nominated for the Orange County Business Journal’s Women in Business Awards and her company, Artemis DNA, won the ACG 2022 Awards for category Start-Up, and also became a member of YPO (Young Presidents’ Organization). Ms. Thai is a graduate of California State University, Long Beach where she earned her Bachelor of Science in Management and Operations Management.

       

  • Ann Sabahat, CPA, MST
    Chief Financial Officer

     

     

    Ms. Ann Sabahat serves as the Chief Financial Officer of Artemis DNA. She is highly versatile, decisive corporate finance executive offering over 25 years of hands-on experience in financial management, with contributions leading to improved financial performance, heightened productivity, and enhanced internal control.

    Ms. Sabahat holds a Masters in Taxation, as well as a CPA license. Her areas of expertise includes: strategic planning, financial and management reporting, mergers and acquisitions, revenue cycle management & automation, debt negotiations, IPO readiness, Sarbanes-Oxley (SOX) and SEC reporting, GAAP & SAP, and regulatory accounting, policies & procedures.

    Prior to Artemis DNA, Ms. Sabahat served as Chief Financial Officer for Karat Packaging Inc, a specialty distributor & manufacturer of single-use disposable food service products company that she helped take public in 2021 (Symbol: KRT) and also as a Corporate Financial Controller for Western Dental and Orthodontics, a $1 billion in revenue multi-state general & specialty dental service provider network.

       

  • Margaret Kivinski, PE, Esq
    Chief Legal Officer & Corporate Secretary

     

     

     

    Ms. Margaret Kivinski is a highly experienced general corporate counsel with intellectual property expertise. She has more than twenty years’ legal experience, primarily in-house with high-growth medical technology companies. She has a strong technical background and demonstrated strengths in patent portfolio growth and management, licensing, litigation management, business contracts and company administration for medical device and pharmaceutical companies.

    Ms. Kivinski received her B.S. in Chemical Engineering from UCLA and is a registered professional engineer in California.  She obtained her J.D. from Western State University College of Law, is admitted to state and federal courts in California, the Ninth and Federal Circuit courts of appeal, and is a registered patent attorney with the USPTO.

       

  • Khanh Thien Nguyen, MD, MRCS, MMED
    Deputy Director

     

     

     

    Dr. Khanh Thien Nguyen, MD, MRCS, MMED is an accomplished doctor, medtech innovator and practicing surgeon. Of note, he has led three clinical trials as co-investigator, published multiple papers and had four utility patents pending in the US as a result of his research.

    Dr. Nguyen serves as the Deputy Director of Clinical Affairs for Artemis DNA, where he oversees all clinical affairs. In addition, Dr. Nguyen has a thriving surgical practice as Chief Medical Officer at AVA Plastic, Reconstructive and Cosmetic Surgery Hospital.

    Dr. Nguyen is a graduate of the University of California, Irvine where he earned his Bachelor of Science Neuroscience with honors, and at Duke-NUS Medical School where he received his Doctor of Medicine. He completed his surgery residency at Singapore General Hospital, the flagship public hospital in Singapore and underwent fellowship in MedTech Innovation at Stanford University in 2016.

     

  • Bryce Van, CPA
    Vice President of Finance & Accounting

     

     

     

    Mr. Bryce Van is the Vice President of Finance and Accounting for Artemis DNA, where he is responsible for developing and implementing various accounting policies and overseeing all aspects of financial reporting for the company.  Previously, Mr. Van served in an accounting and finance leadership role for a publicly traded materials technology firm.

    Mr. Van is a Certified Public Accountant licensed in the state of California and served seven years at PwC as an audit manager for a mix of large and small-cap SEC registrants.

    Mr. Van is a graduate of the University of California, Santa Barbara where he earned his Bachelor of Arts degree in Business Economics with an emphasis in Accounting.

     

  • Lillian Thai
    Vice President of Human Resources

     

     

    Ms. Lillian Thai serves as the Vice President of Human Resources for Artemis DNA, where she oversees all HR operations for the firm including creating and implementing recruitment, training and professional development programs. She also works closely with executive leadership to establish and maintain a positive working environment and to encourage the full use of the diverse talents and abilities of employees. Ms. Thai brings with her more than two decades of management, human resource and client service experience across a variety of industry settings including real estate, finance and retail. Among a number of degrees and certifications, Ms. Thai holds a Certificate in Business Excellence from the Columbia Business School.

     

  • Cynthe Sims, PhD, HCLD (ABB)
    Lab Director

     

     

    Dr. Cynthe Sims has a deep understanding and expertise in clinical laboratory solutions, clinical genomics, precision medicine, molecular diagnostics and next generation sequencing. Dr. Sims has assisted small laboratories, Fortune 500 companies, international government agencies and large healthcare systems plan and launch their precision medicine initiatives.

    Dr. Sims is licensed in the State of Florida (Director License in Molecular Pathology), New York state (COQ) and in California State (CGMBS) and holds HCLD board certification (ABB) in molecular diagnostics.

       

  • Phuong Thanh Thi Le, MD
    Lab Director

     

     

    Dr. Phuong Le serves as the Laboratory Director for Artemis DNA. In this role, she is responsible for oversight of all clinical laboratory testing and ensuring compliance with all requirements for laboratory accreditation across Artemis DNA’s operations.

    Dr. Le has an extensive background working in pathology labs, having previously worked at City International Hospital, and most recently serving as the Head of Tissue Bank at EMCAS Plastic Surgery Hospital, where she implemented their lab techniques and protocols.

    Dr. Le is a graduate of the University of Medicine and Pharmacy at Ho Chi Minh City, where she earned her Doctor of Medicine and her Master of Science in Medicine with a focus in Medical Morphology (Histopathology).

     

  • Reza S. Davoodi, MSc, PhD, HCLD(ABB)
    Associate Lab Director

     

     

     

    Dr. Reza Davoodi has several years’ leadership experience in a CLIA diagnostics laboratory and many years’ experience as a principal investigator in academia conducting translational research. Dr. Davoodi has 24 peer-reviewed published papers. He was awarded several fellowships and grants, including an NIH grant on his research investigating the Jak-Stat signaling pathway to prevent and reverse type-1 diabetes in NOD mice.

    Dr. Davoodi is licensed in the State of Florida (Director License in Molecular Pathology), the New York state (COQ) and in California state (CGMBS) and holds HCLD board certification (ABB) in molecular diagnostics.